Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values t_alt_count t_ref_count validation_alt_allele validation_method validation_status validation_tumor_sample pox qox pox_cutoff isArtifactMode oxoGCut MDGA2 161357 broad.mit.edu 37 14 47426601 47426601 + Missense_Mutation SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr14:47426601C>T ENST00000426342.1 - 9 1917 c.1171G>A c.(1171-1173)Ggg>Agg p.G391R MDGA2_ENST00000357362.3_Missense_Mutation_p.G391R|MDGA2_ENST00000439988.2_Missense_Mutation_p.G620R|MDGA2_ENST00000399232.2_Missense_Mutation_p.G689R NM_182830.3 NP_878250.2 Q7Z553 MDGA2_HUMAN MAM domain containing glycosylphosphatidylinositol anchor 2 620 Ig-like 4. spinal cord motor neuron differentiation anchored to membrane|plasma membrane breast(3)|endometrium(4)|kidney(2)|large_intestine(14)|lung(41)|ovary(4)|pancreas(1)|prostate(1)|stomach(1)|upper_aerodigestive_tract(5) 76 CTGCATCTCCCAGCTCCAGCT 0.358000 14 22 0 0 1 0 0 ZMYM2 7750 broad.mit.edu 37 13 20635254 20635254 + Missense_Mutation SNP T T C TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr13:20635254T>C ENST00000382869.3 + 17 3052 c.2801T>C c.(2800-2802)aTt>aCt p.I934T ZMYM2_ENST00000382870.2_Missense_Mutation_p.I314T|ZMYM2_ENST00000382871.2_Missense_Mutation_p.I934T|ZMYM2_ENST00000382874.2_Missense_Mutation_p.I934T NM_001190965.1|NM_003453.3|NM_197968.2 NP_001177894.1|NP_003444.1|NP_932072.1 Q9UBW7 ZMYM2_HUMAN zinc finger, MYM-type 2 934 regulation of transcription, DNA-dependent|transcription, DNA-dependent PML body ubiquitin conjugating enzyme binding|zinc ion binding large_intestine(3)|lung(3)|ovary(2)|prostate(1)|upper_aerodigestive_tract(1) 10 all_cancers(29;8.65e-21)|all_epithelial(30;1.04e-18)|all_lung(29;6.75e-18)|Lung SC(185;0.0262)|Ovarian(182;0.162) all cancers(112;0.000148)|Epithelial(112;0.000249)|OV - Ovarian serous cystadenocarcinoma(117;0.00816)|Lung(94;0.0173)|LUSC - Lung squamous cell carcinoma(192;0.0856) CCTGCAGCAATTGAGGAGCTA 0.418000 12 8 0 0 1 0 0 TP53 7157 broad.mit.edu 37 17 7578203 7578203 + Missense_Mutation SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr17:7578203C>T ENST00000420246.2 - 6 778 c.646G>A c.(646-648)Gtg>Atg p.V216M TP53_ENST00000455263.2_Missense_Mutation_p.V216M|TP53_ENST00000269305.4_Missense_Mutation_p.V216M|TP53_ENST00000574684.1_Intron|TP53_ENST00000359597.4_Missense_Mutation_p.V216M|TP53_ENST00000413465.2_Missense_Mutation_p.V216M|TP53_ENST00000445888.2_Missense_Mutation_p.V216M NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 216 Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42. V -> A (in sporadic cancers; somatic mutation).|V -> E (in sporadic cancers; somatic mutation).|V -> G (in sporadic cancers; somatic mutation).|V -> L (in sporadic cancers; somatic mutation).|V -> M (in sporadic cancers; somatic mutation).|V -> W (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.V216M(61)|p.V216del(8)|p.0?(8)|p.V216L(7)|p.?(5)|p.V84M(3)|p.V123M(3)|p.V216fs*6(2)|p.H214fs*5(2)|p.V216fs*32(1)|p.V216fs*33(1)|p.S215fs*27(1)|p.S215fs*29(1)|p.V216fs*5(1)|p.V216_Y220delVVVPY(1)|p.D208_V216delDRNTFRHSV(1)|p.D208fs*1(1)|p.S215fs*31(1)|p.S215_V216insX(1)|p.T211fs*28(1)|p.D207_V216del10(1)|p.S215_V218>R(1)|p.S215_V218>M(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) GGCACCACCACACTATGTCGA 0.537000 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 27 2 0 0 1 0 0 ZSCAN31 64288 broad.mit.edu 37 6 28294587 28294587 + Missense_Mutation SNP C C G TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr6:28294587C>G ENST00000414429.1 - 8 1480 c.577G>C c.(577-579)Gaa>Caa p.E193Q ZSCAN31_ENST00000344279.6_Missense_Mutation_p.E193Q|ZSCAN31_ENST00000439158.1_Missense_Mutation_p.E193Q|ZSCAN31_ENST00000396838.2_Missense_Mutation_p.E193Q|ZSCAN31_ENST00000446474.1_Missense_Mutation_p.E34Q zinc finger and SCAN domain containing 31 TTTAAGATTTCTTGCTTTGAT 0.363000 22 41 0 0 1 0 0 CASKIN1 57524 broad.mit.edu 37 16 2230409 2230409 + Missense_Mutation SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr16:2230409C>T ENST00000343516.6 - 18 3052 c.2960G>A c.(2959-2961)aGt>aAt p.S987N NM_020764.3 NP_065815.1 Q8WXD9 CSKI1_HUMAN CASK interacting protein 1 987 Pro-rich. signal transduction cytoplasm breast(1)|central_nervous_system(1)|cervix(1)|endometrium(3)|kidney(2)|liver(1)|lung(7)|ovary(4)|prostate(5)|skin(3) 28 GGCCAGGTCACTGGCCCGCCG 0.716000 6 6 0 0 1 0 0 IGLV3-22 0 broad.mit.edu 37 22 23047176 23047176 + RNA SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr22:23047176C>T ENST00000390307.2 + 0 278 AGATAGTGAGCGGTACCCTGG 0.547000 23 35 0 0 1 0 0 SETX 23064 broad.mit.edu 37 9 135202372 135202372 + Missense_Mutation SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr9:135202372C>T ENST00000372169.2 - 10 4795 c.4613G>A c.(4612-4614)cGg>cAg p.R1538Q SETX_ENST00000224140.5_Missense_Mutation_p.R1538Q|SETX_ENST00000393220.1_Missense_Mutation_p.R1538Q Q7Z333 SETX_HUMAN senataxin 1538 cell death|double-strand break repair|RNA processing cytoplasm|nucleolus|nucleoplasm ATP binding|DNA helicase activity breast(7)|central_nervous_system(1)|cervix(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(7)|large_intestine(25)|liver(1)|lung(36)|ovary(2)|prostate(2)|skin(1)|stomach(4)|upper_aerodigestive_tract(1)|urinary_tract(2) 97 Myeloproliferative disorder(178;0.204) OV - Ovarian serous cystadenocarcinoma(145;6.82e-06)|Epithelial(140;0.000171) CAACTGAGGCCGACTTACAGA 0.368000 23 28 0 0 1 0 0 NLRC4 58484 broad.mit.edu 37 2 32476671 32476671 + Splice_Site SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr2:32476671C>T ENST00000404025.2 - 5 751 c.e5-1 NLRC4_ENST00000402280.1_Splice_Site|NLRC4_ENST00000342905.6_Intron|NLRC4_ENST00000360906.5_Splice_Site Q9NPP4 NLRC4_HUMAN NLR family, CARD domain containing 4 activation of caspase activity|defense response to bacterium|detection of bacterium|interleukin-1 beta secretion|positive regulation of apoptosis cytoplasm ATP binding|magnesium ion binding|protein homodimerization activity breast(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(6)|lung(1)|ovary(3)|skin(2)|stomach(2) 16 Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.208) TGAAAAAGACCTATTAGAGAA 0.448000 22 27 0 0 1 0 0 PDE11A 50940 broad.mit.edu 37 2 178682596 178682596 + Nonsense_Mutation SNP G G A TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr2:178682596G>A ENST00000286063.5 - 8 1950 c.1633C>T c.(1633-1635)Cga>Tga p.R545* PDE11A_ENST00000409504.1_Nonsense_Mutation_p.R187*|PDE11A_ENST00000449286.2_Nonsense_Mutation_p.R187*|PDE11A_ENST00000497003.1_5'UTR|PDE11A_ENST00000389683.3_Nonsense_Mutation_p.R101*|PDE11A_ENST00000358450.4_Nonsense_Mutation_p.R295* NM_016953.3 NP_058649.3 Q9HCR9 PDE11_HUMAN phosphodiesterase 11A 545 GAF 2. platelet activation|signal transduction cytosol 3',5'-cyclic-AMP phosphodiesterase activity|3',5'-cyclic-GMP phosphodiesterase activity|metal ion binding breast(2)|central_nervous_system(1)|endometrium(2)|kidney(2)|large_intestine(13)|lung(28)|ovary(4)|skin(3)|upper_aerodigestive_tract(3) 58 OV - Ovarian serous cystadenocarcinoma(117;0.00121)|Epithelial(96;0.00455)|all cancers(119;0.02) TCAAAAAGTCGTTGATCTGCA 0.378000 Primary Pigmented Nodular Adrenocortical Disease, Familial 20 9 0 0 1 0 0 NUP155 9631 broad.mit.edu 37 5 37364077 37364077 + Missense_Mutation SNP C C G TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr5:37364077C>G ENST00000231498.3 - 3 508 c.305G>C c.(304-306)tGt>tCt p.C102S NUP155_ENST00000381843.2_Missense_Mutation_p.C43S|NUP155_ENST00000513532.1_Missense_Mutation_p.C102S NM_153485.1 NP_705618.1 O75694 NU155_HUMAN nucleoporin 155kDa 102 carbohydrate metabolic process|glucose transport|mRNA transport|nucleocytoplasmic transport|protein transport|regulation of glucose transport|transmembrane transport|viral reproduction nuclear membrane|nuclear pore protein binding|structural constituent of nuclear pore|transporter activity endometrium(1)|kidney(16)|large_intestine(5)|lung(29)|ovary(2)|prostate(1)|skin(3)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2) 62 all_lung(31;0.000137) COAD - Colon adenocarcinoma(61;0.14)|Colorectal(62;0.202) CATGCAATTACACTGCATATC 0.373000 28 39 0 0 1 0 0 MTMR6 9107 broad.mit.edu 37 13 25840284 25840284 + Missense_Mutation SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr13:25840284C>T ENST00000381801.5 - 4 1206 c.445G>A c.(445-447)Gcc>Acc p.A149T MTMR6_ENST00000540661.1_Missense_Mutation_p.A149T NM_004685.3 NP_004676.3 Q9Y217 MTMR6_HUMAN myotubularin related protein 6 149 Myotubularin phosphatase. cytoplasm|nuclear envelope calcium-activated potassium channel activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity breast(2)|endometrium(3)|kidney(3)|large_intestine(5)|lung(12)|ovary(2)|prostate(1)|skin(5)|stomach(3) 36 Lung SC(185;0.0225)|Breast(139;0.0351) all cancers(112;0.00927)|Epithelial(112;0.0474)|OV - Ovarian serous cystadenocarcinoma(117;0.164) TCCCGGTTGGCATCAGACAAC 0.453000 3 23 0 0 1 0 0 NLRP9 338321 broad.mit.edu 37 19 56244772 56244772 + Missense_Mutation SNP G G A TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr19:56244772G>A ENST00000332836.2 - 2 452 c.425C>T c.(424-426)gCg>gTg p.A142V NM_176820.2 NP_789790.2 Q7RTR0 NALP9_HUMAN NLR family, pyrin domain containing 9 142 cytoplasm ATP binding NS(2)|breast(5)|cervix(1)|endometrium(7)|kidney(8)|large_intestine(15)|lung(21)|ovary(2)|prostate(3)|skin(7)|urinary_tract(3) 74 Colorectal(82;0.000133)|Ovarian(87;0.133) GBM - Glioblastoma multiforme(193;0.123) TCGTCTAGCCGCAGCAGTATA 0.433000 36 52 0 0 1 0 0 FGD5 152273 broad.mit.edu 37 3 14861759 14861759 + Missense_Mutation SNP G G C TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr3:14861759G>C ENST00000285046.5 + 1 1291 c.1181G>C c.(1180-1182)tGt>tCt p.C394S FGD5_ENST00000543601.1_Missense_Mutation_p.C153S NM_152536.3 NP_689749.3 Q6ZNL6 FGD5_HUMAN FYVE, RhoGEF and PH domain containing 5 394 actin cytoskeleton organization|filopodium assembly|regulation of Cdc42 GTPase activity|regulation of cell shape cytoskeleton|Golgi apparatus|lamellipodium|ruffle metal ion binding|Rho guanyl-nucleotide exchange factor activity|small GTPase binding NS(2)|breast(2)|endometrium(3)|kidney(5)|large_intestine(10)|lung(25)|ovary(3)|pancreas(1)|prostate(2)|urinary_tract(1) 54 GGGGCTTTGTGTGGCCAGTGT 0.617000 17 22 0 0 1 0 0 FGA 2243 broad.mit.edu 37 4 155507658 155507658 + Missense_Mutation SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr4:155507658C>T ENST00000302053.3 - 5 1001 c.923G>A c.(922-924)cGa>cAa p.R308Q FGA_ENST00000403106.3_Missense_Mutation_p.R308Q NM_000508.3 NP_000499.1 P02671 FIBA_HUMAN fibrinogen alpha chain 308 platelet activation|platelet degranulation|protein polymerization|response to calcium ion|signal transduction external side of plasma membrane|fibrinogen complex|platelet alpha granule lumen eukaryotic cell surface binding|protein binding, bridging|receptor binding p.R308Q(1) NS(1)|breast(5)|central_nervous_system(2)|cervix(1)|endometrium(6)|kidney(2)|large_intestine(14)|liver(2)|lung(20)|ovary(3)|pancreas(1)|prostate(8)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(6) 73 all_hematologic(180;0.215) Renal(120;0.0458) Alteplase(DB00009)|Anistreplase(DB00029)|Reteplase(DB00015)|Sucralfate(DB00364)|Tenecteplase(DB00031) CCCAGGGTTTCGGTTTCCAGT 0.572000 85 104 0 0 1 0 0 NDST3 9348 broad.mit.edu 37 4 118975505 118975505 + Missense_Mutation SNP G G A TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr4:118975505G>A ENST00000296499.5 + 2 843 c.440G>A c.(439-441)cGa>cAa p.R147Q NDST3_ENST00000433996.2_Missense_Mutation_p.R147Q NM_004784.2 NP_004775.1 O95803 NDST3_HUMAN N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 147 Heparan sulfate N-deacetylase 3. Golgi membrane|integral to membrane [heparan sulfate]-glucosamine N-sulfotransferase activity|hydrolase activity NS(1)|breast(3)|cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(11)|lung(23)|prostate(1)|skin(3)|upper_aerodigestive_tract(3)|urinary_tract(1) 54 TCCTGGAATCGAAGCCTTCTA 0.343000 15 20 0 0 1 0 0 CCT6P1 0 broad.mit.edu 37 7 65222986 65222986 + RNA SNP G G T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr7:65222986G>T ENST00000442266.1 + 0 578 GAATTCTGGCGTTTTTTACAA 0.289000 4 20 5.9392e-07 6.16332e-07 1 1 0 GK2 2712 broad.mit.edu 37 4 80327904 80327904 + Missense_Mutation SNP A A G TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr4:80327904A>G ENST00000358842.3 - 1 1468 c.1451T>C c.(1450-1452)aTg>aCg p.M484T NM_033214.2 NP_149991.2 Q14410 GLPK2_HUMAN glycerol kinase 2 484 glycerol-3-phosphate metabolic process mitochondrial outer membrane ATP binding|glycerol kinase activity autonomic_ganglia(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(10)|lung(13)|ovary(2)|prostate(1)|skin(4)|stomach(1)|upper_aerodigestive_tract(2) 39 AAATCGTTCCATCCTGAGAAC 0.507000 53 63 0 0 1 0 0 SPTB 6710 broad.mit.edu 37 14 65258514 65258514 + Silent SNP G G A TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr14:65258514G>A ENST00000389722.3 - 14 2780 c.2727C>T c.(2725-2727)ctC>ctT p.L909L SPTB_ENST00000389721.5_Silent_p.L909L|SPTB_ENST00000542895.1_Silent_p.L909L|SPTB_ENST00000556626.1_Silent_p.L909L|SPTB_ENST00000389720.3_Silent_p.L909L NM_001024858.2 NP_001020029.1 P11277 SPTB1_HUMAN spectrin, beta, erythrocytic 909 actin filament capping|axon guidance cell surface|cytosol|intrinsic to internal side of plasma membrane|protein complex|spectrin|spectrin-associated cytoskeleton actin filament binding|structural constituent of cytoskeleton breast(5)|central_nervous_system(4)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(18)|lung(36)|ovary(8)|pancreas(1)|prostate(4)|skin(10)|urinary_tract(3) 106 all_lung(585;4.15e-09) all cancers(60;4.33e-34)|OV - Ovarian serous cystadenocarcinoma(108;8.32e-20)|BRCA - Breast invasive adenocarcinoma(234;0.0628) TGTTGGCAGCGAGGTTCACAC 0.557000 19 21 0 0 1 0 0 POLR2E 5434 broad.mit.edu 37 19 1090943 1090943 + Silent SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr19:1090943C>T ENST00000215587.7 - 4 676 c.393G>A c.(391-393)ctG>ctA p.L131L POLR2E_ENST00000585838.1_5'UTR|POLR2E_ENST00000586746.1_Silent_p.L131L P19388 RPAB1_HUMAN polymerase (RNA) II (DNA directed) polypeptide E, 25kDa 131 interspecies interaction between organisms|mRNA capping|nuclear mRNA splicing, via spliceosome|positive regulation of viral transcription|protein phosphorylation|termination of RNA polymerase III transcription|transcription elongation from RNA polymerase II promoter|transcription elongation from RNA polymerase III promoter|transcription initiation from RNA polymerase II promoter|transcription-coupled nucleotide-excision repair|viral reproduction DNA-directed RNA polymerase II, core complex DNA binding|DNA-directed RNA polymerase activity endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(1)|lung(4)|skin(2) 11 Acute lymphoblastic leukemia(61;2.53e-14)|all_hematologic(61;8.18e-10)|Lung NSC(49;1.04e-05)|all_lung(49;1.53e-05)|Breast(49;9.42e-05)|Hepatocellular(1079;0.137) UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|OV - Ovarian serous cystadenocarcinoma(105;1.09e-113)|Epithelial(107;3.79e-112)|all cancers(105;1.67e-104)|BRCA - Breast invasive adenocarcinoma(158;0.00136)|STAD - Stomach adenocarcinoma(1328;0.18) GCTCCTGCTGCAGAAACTGCT 0.667000 14 33 0 0 1 0 0 KCNH1 3756 broad.mit.edu 37 1 210856965 210856965 + Missense_Mutation SNP C C G TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr1:210856965C>G ENST00000367007.4 - 11 2716 c.2547G>C c.(2545-2547)aaG>aaC p.K849N KCNH1_ENST00000271751.4_Missense_Mutation_p.K876N NM_002238.3|NM_172362.2 NP_002229.1|NP_758872.1 O95259 KCNH1_HUMAN potassium voltage-gated channel, subfamily H (eag-related), member 1 876 myoblast fusion|regulation of transcription, DNA-dependent voltage-gated potassium channel complex calmodulin binding|delayed rectifier potassium channel activity|two-component sensor activity NS(1)|breast(1)|central_nervous_system(1)|endometrium(5)|kidney(1)|large_intestine(13)|lung(35)|ovary(4)|prostate(4)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1) 68 OV - Ovarian serous cystadenocarcinoma(81;0.0109)|all cancers(67;0.141)|Epithelial(68;0.185) ACGAGTCTGTCTTCTTCAGTG 0.592000 24 49 0 0 1 0 0 RP11-417J8.6 0 broad.mit.edu 37 1 142713407 142713407 + RNA SNP C C T rs142431664 by1000genomes TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr1:142713407C>T ENST00000369381.2 - 0 1198 CAGTAAGAAACTCATTCTTAT 0.318000 5 10 0 0 1 0 0 SLC16A3 9123 broad.mit.edu 37 17 80195561 80195561 + Silent SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr17:80195561C>T ENST00000581287.1 + 3 3237 c.915C>T c.(913-915)aaC>aaT p.N305N SLC16A3_ENST00000392339.1_Silent_p.N305N|SLC16A3_ENST00000392341.1_Silent_p.N305N|SLC16A3_ENST00000582743.1_Silent_p.N305N NM_001206951.1|NM_001206952.1 NP_001193880.1|NP_001193881.1 O15427 MOT4_HUMAN solute carrier family 16 (monocarboxylate transporter), member 3 305 blood coagulation|leukocyte migration|organic anion transport|pyruvate metabolic process actin cytoskeleton|integral to plasma membrane|membrane fraction|nuclear membrane secondary active monocarboxylate transmembrane transporter activity|symporter activity endometrium(2)|kidney(1)|lung(3)|ovary(1)|skin(1)|upper_aerodigestive_tract(1) 9 Breast(20;0.00285)|all_neural(118;0.0804)|Lung NSC(278;0.128)|all_lung(278;0.145)|Ovarian(332;0.227) OV - Ovarian serous cystadenocarcinoma(97;0.00463)|BRCA - Breast invasive adenocarcinoma(99;0.0149) Pyruvic acid(DB00119) TGTTCTTCAACGGCCTCGCGG 0.652000 29 65 0 0 1 0 0 MYT1L 23040 broad.mit.edu 37 2 1843079 1843079 + Silent SNP G G A TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr2:1843079G>A ENST00000399161.2 - 21 3669 c.2922C>T c.(2920-2922)agC>agT p.S974S MYT1L_ENST00000407844.1_5'UTR|MYT1L_ENST00000471668.1_5'UTR|MYT1L_ENST00000428368.2_Silent_p.S972S NM_015025.2 NP_055840.2 Q9UL68 MYT1L_HUMAN myelin transcription factor 1-like 974 cell differentiation|nervous system development nucleus DNA binding|sequence-specific DNA binding transcription factor activity|zinc ion binding breast(1)|central_nervous_system(1)|cervix(2)|endometrium(5)|kidney(6)|large_intestine(16)|lung(50)|ovary(5)|prostate(2)|skin(6)|upper_aerodigestive_tract(1)|urinary_tract(2) 97 Acute lymphoblastic leukemia(172;0.0627)|all_hematologic(175;0.0797) all_cancers(51;0.037)|all_epithelial(98;0.241) OV - Ovarian serous cystadenocarcinoma(76;0.169)|all cancers(51;0.244) ACCCGGAGGCGCTGCGATGGG 0.632000 29 37 0 0 1 0 0 AP3S1 1176 broad.mit.edu 37 5 115177767 115177767 + Silent SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr5:115177767C>T ENST00000316788.7 + 1 590 c.33C>T c.(31-33)caC>caT p.H11H NM_001284.2 NP_001275.1 Q92572 AP3S1_HUMAN adaptor-related protein complex 3, sigma 1 subunit 11 insulin receptor signaling pathway|intracellular protein transport|vesicle-mediated transport AP-type membrane coat adaptor complex|cytoplasmic vesicle membrane|Golgi apparatus|transport vesicle protein binding|protein transporter activity cervix(1)|endometrium(2)|kidney(1)|large_intestine(3)|lung(2)|ovary(1)|pancreas(1)|prostate(1) 12 all_cancers(142;0.00377)|all_epithelial(76;0.000129)|Prostate(80;0.0132)|Ovarian(225;0.0776)|Lung NSC(810;0.245) OV - Ovarian serous cystadenocarcinoma(64;1.08e-07)|Epithelial(69;1.11e-06)|all cancers(49;5.2e-05) TCAACAACCACGGGAAGCCGC 0.706000 6 4 0 0 1 0 0 LUC7L2 51631 broad.mit.edu 37 7 139030301 139030301 + Missense_Mutation SNP A A C TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr7:139030301A>C ENST00000541515.3 + 2 218 c.193A>C c.(193-195)Acc>Ccc p.T65P C7orf55_ENST00000481123.1_3'UTR|C7orf55_ENST00000297534.6_Missense_Mutation_p.T65P|C7orf55-LUC7L2_ENST00000541170.3_Intron NM_001244584.1 NP_001231513.1 Q9Y383 LC7L2_HUMAN LUC7-like 2 (S. cerevisiae) 0 enzyme binding|metal ion binding NS(2)|breast(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(3)|lung(3)|skin(1)|urinary_tract(1) 16 Melanoma(164;0.242) CCAAGCTGCCACCTATCTCTG 0.512000 59 63 0 0 1 0 0 MYH6 4624 broad.mit.edu 37 14 23855275 23855275 + Silent SNP G G A TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr14:23855275G>A ENST00000405093.3 - 34 5095 c.5025C>T c.(5023-5025)atC>atT p.I1675I MYH6_ENST00000356287.3_Silent_p.I1675I NM_002471.3 NP_002462.2 P13533 MYH6_HUMAN myosin, heavy chain 6, cardiac muscle, alpha 1675 adult heart development|atrial cardiac muscle tissue morphogenesis|cardiac muscle fiber development|in utero embryonic development|muscle filament sliding|regulation of ATPase activity|regulation of blood pressure|regulation of heart rate|regulation of the force of heart contraction|sarcomere organization|striated muscle contraction|ventricular cardiac muscle tissue morphogenesis|visceral muscle development cytosol|focal adhesion|muscle myosin complex|myosin filament|nucleus|sarcomere actin binding|actin-dependent ATPase activity|ATP binding|calmodulin binding|microfilament motor activity|protein kinase binding|structural constituent of muscle breast(4)|cervix(2)|endometrium(8)|kidney(2)|large_intestine(16)|liver(1)|lung(60)|ovary(2)|pancreas(3)|prostate(6)|skin(6)|stomach(3)|upper_aerodigestive_tract(4)|urinary_tract(2) 119 all_cancers(95;2.54e-05) GBM - Glioblastoma multiforme(265;0.00764)|READ - Rectum adenocarcinoma(4;0.0289)|Colorectal(4;0.0441) GCCGCTCCACGATGGCGATGT 0.637000 18 28 0 0 1 0 0 R3HDML 140902 broad.mit.edu 37 20 42979326 42979326 + Missense_Mutation SNP A A G TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr20:42979326A>G ENST00000217043.2 + 5 828 c.656A>G c.(655-657)tAc>tGc p.Y219C RP5-881L22.5_ENST00000438702.1_RNA NM_178491.2 NP_848586.1 Q9H3Y0 CRSPL_HUMAN R3H domain containing-like 219 extracellular region peptidase inhibitor activity NS(1)|breast(2)|endometrium(1)|kidney(1)|large_intestine(2)|lung(14) 21 Myeloproliferative disorder(115;0.028) COAD - Colon adenocarcinoma(18;0.00189) GAGTCCCCGTACAAGATGGGA 0.532000 33 39 0 0 1 0 0 CCNF 899 broad.mit.edu 37 16 2499351 2499351 + Missense_Mutation SNP C C A rs151164394 TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr16:2499351C>A ENST00000397066.4 + 12 1375 c.1287C>A c.(1285-1287)caC>caA p.H429Q NM_001761.2 NP_001752.2 P41002 CCNF_HUMAN cyclin F 429 cell division|mitosis|negative regulation of centrosome duplication|protein ubiquitination|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process centriole|nucleus|SCF ubiquitin ligase complex protein binding breast(3)|central_nervous_system(1)|kidney(4)|large_intestine(2)|lung(5)|prostate(4)|skin(1) 20 Ovarian(90;0.17) GAACCCAGCACCTGTGCAGCT 0.662000 13 20 0.00010058 0.000102442 1 1 0 TLR4 7099 broad.mit.edu 37 9 120475558 120475558 + Silent SNP C C A TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr9:120475558C>A ENST00000355622.6 + 3 1253 c.1152C>A c.(1150-1152)ggC>ggA p.G384G TLR4_ENST00000472304.1_3'UTR|TLR4_ENST00000394487.4_Silent_p.G344G NM_138554.4|NM_138557.2 NP_612564.1|NP_612567.1 O00206 TLR4_HUMAN toll-like receptor 4 384 activation of MAPK activity|cellular response to mechanical stimulus|detection of fungus|detection of lipopolysaccharide|I-kappaB phosphorylation|innate immune response|intestinal epithelial structure maintenance|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|negative regulation of ERK1 and ERK2 cascade|negative regulation of interferon-gamma production|negative regulation of interleukin-17 production|negative regulation of interleukin-23 production|negative regulation of interleukin-6 production|negative regulation of osteoclast differentiation|negative regulation of tumor necrosis factor production|positive regulation of chemokine production|positive regulation of interferon-alpha production|positive regulation of interferon-beta production|positive regulation of interferon-gamma production|positive regulation of interleukin-1 production|positive regulation of interleukin-10 production|positive regulation of interleukin-12 biosynthetic process|positive regulation of interleukin-12 production|positive regulation of interleukin-6 production|positive regulation of interleukin-8 biosynthetic process|positive regulation of interleukin-8 production|positive regulation of NF-kappaB import into nucleus|positive regulation of NF-kappaB transcription factor activity|positive regulation of nitric-oxide synthase biosynthetic process|positive regulation of platelet activation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of tumor necrosis factor production|T-helper 1 type immune response|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 4 signaling pathway external side of plasma membrane|integral to plasma membrane|lipopolysaccharide receptor complex|perinuclear region of cytoplasm lipopolysaccharide receptor activity|transmembrane receptor activity breast(2)|central_nervous_system(1)|endometrium(3)|kidney(2)|large_intestine(12)|lung(66)|ovary(4)|pancreas(1)|skin(6)|upper_aerodigestive_tract(5)|urinary_tract(1) 103 GTAGAAATGGCTTGAGTTTCA 0.383000 19 30 1.96292e-10 2.11688e-10 1 1 0 GUCA1B 2979 broad.mit.edu 37 6 42162502 42162502 + Silent SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr6:42162502C>T ENST00000230361.3 - 1 152 c.57G>A c.(55-57)gcG>gcA p.A19A NM_002098.5 NP_002089.4 Q9UMX6 GUC1B_HUMAN guanylate cyclase activator 1B (retina) 19 EF-hand 1. body fluid secretion|cell-cell signaling|receptor guanylyl cyclase signaling pathway|visual perception plasma membrane calcium ion binding|calcium sensitive guanylate cyclase activator activity large_intestine(3)|lung(3)|skin(2) 8 Colorectal(47;0.196) Colorectal(64;0.00062)|COAD - Colon adenocarcinoma(64;0.00152)|Epithelial(12;0.00154)|STAD - Stomach adenocarcinoma(11;0.00177) CCTGGAGCTCCGCCACATCTA 0.562000 6 8 0 0 1 0 0 DNAH1 25981 broad.mit.edu 37 3 52428569 52428569 + Missense_Mutation SNP G G A TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr3:52428569G>A ENST00000420323.2 + 67 10976 c.10715G>A c.(10714-10716)cGa>cAa p.R3572Q NM_015512.4 NP_056327.4 Q9P2D7 DYH1_HUMAN dynein, axonemal, heavy chain 1 3637 ciliary or flagellar motility|microtubule-based movement|response to mechanical stimulus axonemal dynein complex|cilium axoneme|cytoplasm|microtubule ATP binding|ATPase activity|microtubule motor activity cervix(2)|endometrium(18)|kidney(6)|large_intestine(3)|lung(31)|prostate(1)|urinary_tract(1) 62 BRCA - Breast invasive adenocarcinoma(193;2.02e-05)|OV - Ovarian serous cystadenocarcinoma(275;0.000207)|Kidney(197;0.0022)|KIRC - Kidney renal clear cell carcinoma(197;0.00245) CGGGCTTGGCGAGACATCCTA 0.577000 20 36 0 0 1 0 0 LCT 3938 broad.mit.edu 37 2 136566631 136566631 + Missense_Mutation SNP C C T rs146467199 byFrequency TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr2:136566631C>T ENST00000264162.2 - 8 3296 c.3286G>A c.(3286-3288)Gcc>Acc p.A1096T NM_002299.2 NP_002290.2 P09848 LPH_HUMAN lactase 1096 4 X approximate repeats. A -> T (in Ref. 1; CAA30801). carbohydrate metabolic process|polysaccharide digestion apical plasma membrane|integral to plasma membrane|membrane fraction cation binding|glycosylceramidase activity|lactase activity breast(6)|central_nervous_system(3)|cervix(1)|endometrium(8)|kidney(2)|large_intestine(26)|lung(57)|ovary(7)|pancreas(2)|prostate(1)|skin(3)|upper_aerodigestive_tract(4)|urinary_tract(4) 124 BRCA - Breast invasive adenocarcinoma(221;0.169) TTGATGACGGCGTGGGCTATC 0.552000 18 29 0 0 1 0 0 CYP2C19 1557 broad.mit.edu 37 10 96612622 96612622 + Missense_Mutation SNP G G A TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr10:96612622G>A ENST00000371321.3 + 9 1506 c.1424G>A c.(1423-1425)gGa>gAa p.G475E CYP2C19_ENST00000464755.1_3'UTR NM_000769.1 NP_000760.1 P33261 CP2CJ_HUMAN cytochrome P450, family 2, subfamily C, polypeptide 19 475 exogenous drug catabolic process|heterocycle metabolic process|monoterpenoid metabolic process|steroid metabolic process|xenobiotic metabolic process endoplasmic reticulum membrane|microsome (S)-limonene 6-monooxygenase activity|(S)-limonene 7-monooxygenase activity|4-hydroxyacetophenone monooxygenase activity|electron carrier activity|enzyme binding|heme binding|oxygen binding|steroid hydroxylase activity central_nervous_system(2)|endometrium(1)|kidney(2)|large_intestine(5)|lung(17)|ovary(4)|prostate(1)|skin(5)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(1) 43 Colorectal(252;0.09) all cancers(201;6.02e-07)|KIRC - Kidney renal clear cell carcinoma(50;0.0672)|Kidney(138;0.0838) Adinazolam(DB00546)|Aminophenazone(DB01424)|Amitriptyline(DB00321)|Amoxicillin(DB01060)|Arformoterol(DB01274)|Bortezomib(DB00188)|Carisoprodol(DB00395)|Chlorzoxazone(DB00356)|Cilostazol(DB01166)|Citalopram(DB00215)|Clarithromycin(DB01211)|Clobazam(DB00349)|Desipramine(DB01151)|Desloratadine(DB00967)|Diclofenac(DB00586)|Diltiazem(DB00343)|Efavirenz(DB00625)|Esomeprazole(DB00736)|Famotidine(DB00927)|Felbamate(DB00949)|Finasteride(DB01216)|Flunitrazepam(DB01544)|Fluvoxamine(DB00176)|Formoterol(DB00983)|Fosphenytoin(DB01320)|Guanfacine(DB01018)|Imipramine(DB00458)|Indomethacin(DB00328)|Ketoconazole(DB01026)|Lansoprazole(DB00448)|Lapatinib(DB01259)|Loratadine(DB00455)|Melatonin(DB01065)|Mephenytoin(DB00532)|Methadone(DB00333)|Methylphenobarbital(DB00849)|Moclobemide(DB01171)|Modafinil(DB00745)|Nelfinavir(DB00220)|Nicardipine(DB00622)|Nilutamide(DB00665)|Norgestrel(DB00506)|Omeprazole(DB00338)|Oxcarbazepine(DB00776)|Pantoprazole(DB00213)|Pentamidine(DB00738)|Phenobarbital(DB01174)|Phenytoin(DB00252)|Primidone(DB00794)|Progesterone(DB00396)|Proguanil(DB01131)|Promazine(DB00420)|Quinidine(DB00908)|Rabeprazole(DB01129)|Ranitidine(DB00863)|Ritonavir(DB00503)|Selegiline(DB01037)|Sertraline(DB01104)|Temazepam(DB00231)|Teniposide(DB00444)|Terfenadine(DB00342)|Thalidomide(DB01041)|Thioridazine(DB00679)|Ticlopidine(DB00208)|Tolbutamide(DB01124)|Topiramate(DB00273)|Tranylcypromine(DB00752)|Troglitazone(DB00197)|Troleandomycin(DB01361)|Voriconazole(DB00582) GTTGTCAATGGATTTGCTTCT 0.473000 40 8 0 0 1 0 0 EDAR 10913 broad.mit.edu 37 2 109527457 109527457 + Missense_Mutation SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr2:109527457C>T ENST00000409271.1 - 8 1044 c.601G>A c.(601-603)Gcc>Acc p.A201T EDAR_ENST00000376651.1_Missense_Mutation_p.A201T|EDAR_ENST00000258443.2_Missense_Mutation_p.A201T Q9UNE0 EDAR_HUMAN ectodysplasin A receptor 201 apoptosis|cell differentiation integral to membrane protein binding|transmembrane receptor activity NS(1)|breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|large_intestine(3)|lung(6)|prostate(1)|skin(1) 16 aggacgatggcgatggccatg 0.577000 16 21 0 0 1 0 0 TPPP 11076 broad.mit.edu 37 5 665358 665358 + Silent SNP C C A TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr5:665358C>A ENST00000360578.5 - 4 640 c.519G>T c.(517-519)acG>acT p.T173T CEP72_ENST00000514507.1_3'UTR NM_007030.2 NP_008961.1 O94811 TPPP_HUMAN tubulin polymerization promoting protein 173 microtubule bundle formation|microtubule polymerization|positive regulation of protein polymerization nucleus|perinuclear region of cytoplasm|soluble fraction calcium ion binding|microtubule binding kidney(1)|large_intestine(1)|lung(2)|prostate(1) 5 Ovarian(839;0.0563) Epithelial(17;0.000445)|all cancers(22;0.00176)|OV - Ovarian serous cystadenocarcinoma(19;0.00227)|Lung(60;0.0863) GBM - Glioblastoma multiforme(108;0.0191) TGTGGGAGCCCGTGAACTTGG 0.632000 3 34 0.004672 0.004672 1 1 0 MSLNL 401827 broad.mit.edu 37 16 823215 823215 + Missense_Mutation SNP A A G TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr16:823215A>G ENST00000293892.3 - 10 2052 c.2053T>C c.(2053-2055)Tgc>Cgc p.C685R MSLNL_ENST00000442466.1_Missense_Mutation_p.C334R Q96KJ4 MSLNL_HUMAN mesothelin-like 334 cell adhesion integral to membrane breast(4)|central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|lung(15)|ovary(2)|pancreas(2)|prostate(4)|skin(1)|urinary_tract(2) 36 CTGAGGATGCAGCCATCCAGG 0.632000 24 32 0 0 1 0 0 TAAR5 9038 broad.mit.edu 37 6 132910545 132910545 + Missense_Mutation SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr6:132910545C>T ENST00000258034.2 - 1 332 c.281G>A c.(280-282)cGc>cAc p.R94H NM_003967.2 NP_003958.2 O14804 TAAR5_HUMAN trace amine associated receptor 5 94 synaptic transmission integral to plasma membrane G-protein coupled receptor activity breast(1)|cervix(1)|endometrium(1)|kidney(3)|large_intestine(9)|lung(15)|skin(1)|upper_aerodigestive_tract(1) 32 Breast(56;0.112) OV - Ovarian serous cystadenocarcinoma(155;0.00604)|GBM - Glioblastoma multiforme(226;0.015) CTCCACTGAGCGAATGGTGCT 0.587000 27 47 0 0 1 0 0 OR9G1 390174 broad.mit.edu 37 11 56468437 56468437 + Missense_Mutation SNP G G A TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr11:56468437G>A ENST00000312153.1 + 1 574 c.574G>A c.(574-576)Ggc>Agc p.G192S NM_001005213.1 NP_001005213.1 olfactory receptor, family 9, subfamily G, member 1 breast(2)|kidney(1)|lung(25)|stomach(2)|upper_aerodigestive_tract(1) 31 TGGCGAGAAGGGCGGCTATAA 0.478000 25 56 0 0 1 0 0 PLAG1 5324 broad.mit.edu 37 8 57079207 57079207 + Silent SNP G G A TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr8:57079207G>A ENST00000316981.3 - 5 1577 c.1098C>T c.(1096-1098)ggC>ggT p.G366G PLAG1_ENST00000423799.2_Silent_p.G284G|PLAG1_ENST00000429357.2_Silent_p.G366G NM_001114634.1|NM_002655.2 NP_001108106.1|NP_002646.2 Q6DJT9 PLAG1_HUMAN pleiomorphic adenoma gene 1 366 Activates transcription; Inhibition of nuclear import due to lack of NLS and KPNA2 interaction.|Repression domain; contains 3 sumoylation motifs and massively decrease transcription activity. nucleus DNA binding|sequence-specific DNA binding transcription factor activity|zinc ion binding p.G366G(2) CTNNB1/PLAG1(60)|LIFR_ENST00000263409/PLAG1(10)|HAS2/PLAG1(10)|FGFR1_ENST00000447712/PLAG1(28)|COL1A2/PLAG1(3)|CHCHD7/PLAG1(12)|TCEA1_ENST00000521604/PLAG1(3) breast(3)|central_nervous_system(1)|cervix(1)|kidney(2)|large_intestine(7)|lung(11)|prostate(1)|skin(1)|upper_aerodigestive_tract(1) 28 all_lung(136;0.0548)|Lung NSC(129;0.0718)|all_epithelial(80;0.125) Epithelial(17;0.00179)|all cancers(17;0.0125) AAGAGGGCACGCCACCTTGTA 0.458000 T """TCEA1, LIFR, CTNNB1, CHCHD7""" salivary adenoma 92 66 0 0 1 0 0 KRT6B 3854 broad.mit.edu 37 12 52842747 52842747 + Missense_Mutation SNP T T C TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr12:52842747T>C ENST00000252252.3 - 6 1129 c.1082A>G c.(1081-1083)gAg>gGg p.E361G NM_005555.3 NP_005546.2 P04259 K2C6B_HUMAN keratin 6B 361 Coil 2.|Rod. ectoderm development keratin filament structural constituent of cytoskeleton NS(1)|breast(2)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(3)|lung(19)|ovary(4)|prostate(2) 40 BRCA - Breast invasive adenocarcinoma(357;0.083) CTGCAGCTCCTCGTACTGCAG 0.537000 37 54 0 0 1 0 0 AIPL1 23746 broad.mit.edu 37 17 6329143 6329143 + Silent SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr17:6329143C>T ENST00000381129.3 - 6 872 c.792G>A c.(790-792)gtG>gtA p.V264V AIPL1_ENST00000250087.5_Silent_p.V201V|AIPL1_ENST00000570466.1_Silent_p.V242V|AIPL1_ENST00000576776.1_Silent_p.V240V|AIPL1_ENST00000576307.1_Silent_p.V204V|AIPL1_ENST00000575265.1_3'UTR|AIPL1_ENST00000574506.1_Silent_p.V252V NM_001033055.1|NM_014336.3 NP_001028227.1|NP_055151.3 Q9NZN9 AIPL1_HUMAN aryl hydrocarbon receptor interacting protein-like 1 264 protein farnesylation|protein folding|visual perception cytoplasm|nucleus farnesylated protein binding|unfolded protein binding NS(1)|kidney(1)|large_intestine(2)|liver(1)|lung(5)|ovary(1)|skin(1) 12 COAD - Colon adenocarcinoma(228;0.141) AGTAGGCCTTCACGATGCCTG 0.657000 21 4 0 0 1 0 0 ADH1A 124 broad.mit.edu 37 4 100205899 100205899 + Silent SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr4:100205899C>T ENST00000209668.2 - 4 434 c.321G>A c.(319-321)ccG>ccA p.P107P RP11-696N14.1_ENST00000500358.2_RNA NM_000667.3 NP_000658.1 P07327 ADH1A_HUMAN alcohol dehydrogenase 1A (class I), alpha polypeptide 107 ethanol oxidation|transcription, DNA-dependent|xenobiotic metabolic process cytosol alcohol dehydrogenase activity, zinc-dependent|protein binding|zinc ion binding endometrium(2)|kidney(2)|large_intestine(3)|lung(11)|ovary(1)|prostate(1)|skin(4)|stomach(1) 25 OV - Ovarian serous cystadenocarcinoma(123;9.56e-08) Fomepizole(DB01213)|NADH(DB00157) AGTTGCTCTCCGGGTTTTTAC 0.418000 18 26 0 0 1 0 0 NOS1 4842 broad.mit.edu 37 12 117723945 117723945 + Silent SNP C C T TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr12:117723945C>T ENST00000317775.6 - 6 1939 c.1254G>A c.(1252-1254)tcG>tcA p.S418S NOS1_ENST00000344089.3_3'UTR|NOS1_ENST00000338101.4_Silent_p.S418S NM_000620.4|NM_001204218.1 NP_000611.1|NP_001191147.1 P29475 NOS1_HUMAN nitric oxide synthase 1 (neuronal) 418 multicellular organismal response to stress|myoblast fusion|negative regulation of calcium ion transport into cytosol|neurotransmitter biosynthetic process|nitric oxide biosynthetic process|platelet activation|positive regulation of vasodilation|regulation of cardiac muscle contraction|response to heat|response to hypoxia cytoskeleton|cytosol|dendritic spine|perinuclear region of cytoplasm|photoreceptor inner segment|sarcolemma|sarcoplasmic reticulum arginine binding|cadmium ion binding|calmodulin binding|flavin adenine dinucleotide binding|FMN binding|heme binding|NADP binding|nitric-oxide synthase activity|tetrahydrobiopterin binding NS(1)|breast(1)|central_nervous_system(3)|endometrium(11)|haematopoietic_and_lymphoid_tissue(1)|kidney(17)|large_intestine(21)|lung(43)|ovary(3)|pancreas(1)|prostate(6)|skin(6)|upper_aerodigestive_tract(2)|urinary_tract(1) 117 all_neural(191;0.0804)|Medulloblastoma(191;0.0922) BRCA - Breast invasive adenocarcinoma(302;0.0561) L-Citrulline(DB00155) CCACACAGCGCGAGGCATTCC 0.562000 31 51 0 0 1 0 0 AP001347.6 0 broad.mit.edu 37 21 15399864 15399864 + RNA SNP T T C rs2298673 by1000genomes TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr21:15399864T>C ENST00000428809.1 + 0 123 TGTGACCTGCTGGCATTGAAT 0.587000 3 39 0 0 1 0 0 TMPRSS11F 389208 broad.mit.edu 37 4 68925146 68925146 + Frame_Shift_Del DEL G G - TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr4:68925146delG ENST00000356291.2 - 9 1115 c.1056delC c.(1054-1056)acfs p.T352fs RP11-453E17.1_ENST00000500538.2_RNA NM_207407.2 NP_997290.2 Q6ZWK6 TM11F_HUMAN transmembrane protease, serine 11F 352 Peptidase S1. proteolysis extracellular region|integral to plasma membrane serine-type endopeptidase activity NS(1)|breast(1)|endometrium(2)|kidney(2)|large_intestine(7)|liver(1)|lung(18)|ovary(1)|pancreas(1)|prostate(1)|urinary_tract(4) 39 CAGTGCTTATGGTTTCCACTC 0.363 21 30 --- --- --- --- HLA-V 0 broad.mit.edu 37 6 29760353 29760373 + RNA DEL GCGGGCGCCGTGGATGGAGCA GCGGGCGCCGTGGATGGAGCA - rs74661005 by1000genomes TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr6:29760353_29760373delGCGGGCGCCGTGGATGGAGCA ENST00000457107.1 + 0 223_243 GGATGGAGCCGCGGGCGCCGTGGATGGAGCAGGAGGGGCCG 0.674 3 6 --- --- --- --- LA16c-23H5.4 0 broad.mit.edu 37 22 16419352 16419352 + RNA DEL T T - TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-10A-01D-2024-08 Untested Somatic Phase_I WXS none Illumina GAIIx f0eb92a8-7607-4cfb-b2a5-a65aa707a4b7 e7a1b446-ae3d-4f8f-a976-fdaa7902e760 g.chr22:16419352delT ENST00000444162.1 + 0 279 GAATCGACGATTTTTTTTTTG 0.398 5 5 --- --- --- ---